Prevalence and predictors of complementary and alternative medicine use in African-Americans with acquired immune deficiency syndrome.

Focus on Alternative and Complementary Therapies : FACT
A Owen-SmithR Diclemente

Abstract

BACKGROUND: The use of complementary and alternative medicine (CAM) among Human Immunodeficiency Virus (HIV)-positive individuals is becoming increasingly widespread. Unfortunately, some CAM therapies may jeopardize the efficacy of conventional HIV medication, making it critical to understand CAM use among this population. OBJECTIVE: To investigate the prevalence and predictors of CAM use in a theory-driven, multidimensional manner. METHODS: African-American individuals who had received a diagnosis of acquired immune deficiency syndrome (AIDS) were recruited. The computer-administered survey asked questions about participants' CAM use and various psychosocial and socio-demographic characteristics. Participants' most recent CD4+ cell counts and HIV RNA levels were abstracted from medical records. Linear regression analyses, adjusted for potential confounders, were conducted to assess the independent contribution of various factors in explaining frequency of CAM use. RESULTS: One hundred and eighty two subjects participated in the survey. Results indicate that most (94%) participants used at least one type of CAM therapy. The majority of participants (79.7%) used CAM therapies as a complement (rather than an alternative) to th...Continue Reading

References

Jan 1, 1978·Health Education Monographs·K A WallstonR DeVellis
Mar 9, 1989·The New England Journal of Medicine·S Kent, E Weinberg
Jan 1, 1995·The Journal of the Association of Nurses in AIDS Care : JANAC·J T DwyerW D Selles
Mar 1, 1995·Journal of Health and Social Behavior·R M Andersen
Oct 1, 1994·Journal of Psychosomatic Research·W LangewitzA Kiss
Aug 1, 1996·Journal of Behavioral Medicine·E WulfertC A Backus
Jun 1, 1997·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·M J OstrowR S Hogg
May 30, 1998·JAMA : the Journal of the American Medical Association·J A Astin
Nov 20, 1998·JAMA : the Journal of the American Medical Association·D M EisenbergR C Kessler
Oct 12, 1999·JAMA : the Journal of the American Medical Association·B G Druss, R A Rosenheck
Feb 16, 2000·Lancet·A Fugh-Berman
Feb 22, 2000·Lancet·S C PiscitelliJ Falloon
Jul 15, 2000·Pharmacology & Toxicology·S Beckmann-KnoppU Fuhr
Feb 13, 2001·BMJ : British Medical Journal·M EscherG Mentha
Mar 29, 2001·AIDS·M M de MaatJ H Beijnen
Apr 21, 2001·AIDS Patient Care and STDs·J DugganJ Charkraborty
Feb 1, 1996·AIDS Patient Care and STDs·B R BatesR E Bessinger
Aug 21, 2001·Annals of Internal Medicine·R C KesslerD M Eisenberg
Dec 12, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stephen C PiscitelliJudith Falloon
Dec 26, 2001·Journal of Clinical Epidemiology·A C JusticeUNKNOWN Adult AIDS Clinical Trials Unit Outcomes Committee
Oct 25, 2002·International Journal of STD & AIDS·Kathleen J RisaNina Singh
Apr 5, 2003·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Ioana BicaIra B Wilson
May 10, 2003·AIDS Patient Care and STDs·Michelle D FurlerReina Bendayan
May 30, 2003·American Journal of Public Health·Andrew S LondonMartin F Shapiro
Mar 24, 2004·Integrative Cancer Therapies·Keith I Block, Mark N Mead
Jun 11, 2004·Advance Data·Patricia M BarnesRichard L Nahin
Oct 16, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Isis S MikhailPauline E Jolly
Jan 15, 2005·Behavioral Medicine·Susan P Milden, Daniel Stokols
Apr 26, 2005·Journal of Community Health·Nancy CotugnaKara M Carpenter-Haefele
Aug 4, 2005·BMC Medical Informatics and Decision Making·Anthony K WaruruThorkild Tylleskär
Dec 13, 2005·Annals of Family Medicine·Barry D WeissFrank A Hale
May 2, 2006·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·An-Fu HsiaoNeil S Wenger
Jun 7, 2006·Medical Informatics and the Internet in Medicine·D B FriedmanJ F Arocha
Jul 28, 2006·British Journal of Health Psychology·Margaret A ChesneySusan Folkman
Oct 13, 2007·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Carolyn M BrownThomas M Bohman
Oct 14, 2008·AIDS Patient Care and STDs·Felise B MilanMayris P Webber

❮ Previous
Next ❯

Citations

Mar 15, 2015·The Journal of the Association of Nurses in AIDS Care : JANAC·Graeme DonaldPaul Flowers
Apr 17, 2013·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Luther GwazaB Joseph Guglielmo
Jan 21, 2014·Explore : the Journal of Science and Healing·Erica B ObergRyan Bradley
Feb 15, 2015·International Journal of STD & AIDS·Lesley A BraunAlison J Duncan
Mar 10, 2020·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·Matthew J Leach
Sep 16, 2016·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Natalie E Kelso-ChichettoRobert L Cook
Jan 5, 2017·Evidence-based Complementary and Alternative Medicine : ECAM·Joana Abou-RizkFarah Naja

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.